Triall (TRL) is a token of an end-to-end platform for data collection and research management. Triall solutions are designed to support any therapeutic area, research design, and research phase. The platform offers advanced integration capabilities with websites, mobile devices and wearables to support remote data collection and study management.

Triall (TRL) news

Triall

Twitter

#TRLInsights - According to IQVIA Institute, the past 5 years has seen a rising number of first-in-class medicines.

In 2022, 62% of launches included first-in-class therapies, reflecting the increasing availability of novel science for patients.

Source: https://t.co/4g1orDbe2S